HT
MYGN icon

HAP Trading’s Myriad Genetics MYGN Stock Holding History

HAP Trading’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-200,200
Closed -$66K – 1271
2019
Q1 		$66K Buy
+200,200
New +$6.09M 0.01% 616
2017
Q1 		– Sell
-1,154,700
Closed -$129K – 1202
2016
Q4 		$129K Buy
+1,154,700
New +$20.9M 0.01% 534
2014
Q4 		– Sell
-35,000
Closed -$352K – 1157
2014
Q3 		$352K Hold
35,000
– – 0.01% 514
2014
Q2 		$378K Buy
+35,000
New +$1.3M 0.01% 497
2014
Q1 		– Sell
-350,100
Closed -$493K – 1269
2013
Q4 		$493K Buy
350,100
+34,200
+11% +$865K 0.02% 580
2013
Q3 		$523K Buy
+315,900
New +$8.97M 0.02% 520

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HAP Trading's MYGN Position: Q3 2017 in Review

HAP Trading sold out of Myriad Genetics (MYGN) in Q3 2017, closing a stake of 13,942 shares — an estimated $360K sold.

HAP Trading first reported a position in MYGN in Q3 2013 and held it in 6 quarters. The position peaked at $4.17M in Q3 2013. 220 funds tracked by Wall St. Rank hold MYGN as of Q3 2017.

  • HAP Trading reported no remaining Myriad Genetics position as of Q3 2017 after selling out during the quarter.
  • HAP Trading sold 13,942 Myriad Genetics shares in Q3 2017, an estimated $360K.
  • HAP Trading first reported a position in Myriad Genetics in Q3 2013 and held it in 6 quarters.
  • HAP Trading's Myriad Genetics position peaked at $4.17M in Q3 2013.
  • 220 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2017.

Based on HAP Trading's 13F filing for Q3 2017, filed 8 Nov 2017.